These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33399225)

  • 1. Malignant hyperthermia 2020: Guideline from the Association of Anaesthetists.
    Hopkins PM; Girard T; Dalay S; Jenkins B; Thacker A; Patteril M; McGrady E
    Anaesthesia; 2021 May; 76(5):655-664. PubMed ID: 33399225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant hyperthermia.
    Ben Abraham R; Adnet P; Glauber V; Perel A
    Postgrad Med J; 1998 Jan; 74(867):11-7. PubMed ID: 9538480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report.
    Miyazaki N; Kobayashi T; Komiya T; Okada T; Ishida Y; Fukui H; Ogihara Y; Uchino H
    J Med Case Rep; 2021 Apr; 15(1):201. PubMed ID: 33863374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Malignant hyperthermia--a hereditary and potentially life-threatening condition].
    Haugen T; Toft M; Müller CR; Aasly J
    Tidsskr Nor Laegeforen; 2005 Oct; 125(20):2792-4. PubMed ID: 16244682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines.
    Glahn KPE; Bendixen D; Girard T; Hopkins PM; Johannsen S; Rüffert H; Snoeck MM; Urwyler A;
    Br J Anaesth; 2020 Aug; 125(2):133-140. PubMed ID: 32591088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant hyperthermia in a patient with Graves' disease during subtotal thyroidectomy.
    Nishiyama K; Kitahara A; Natsume H; Matsushita A; Nakano K; Sasaki S; Genma R; Yamamoto Y; Nakamura H
    Endocr J; 2001 Apr; 48(2):227-32. PubMed ID: 11456272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology and Treatment of Malignant Hyperthermia.
    Gregory H; Weant KA
    Adv Emerg Nurs J; 2021 Apr-Jun 01; 43(2):102-110. PubMed ID: 33915557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant hyperthermia.
    Ali SZ; Taguchi A; Rosenberg H
    Best Pract Res Clin Anaesthesiol; 2003 Dec; 17(4):519-33. PubMed ID: 14661655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malignant hyperthermia].
    Bouhajja B; Haddad F; Ben Ammar MS
    Tunis Med; 2002 Jul; 80(7):395-401. PubMed ID: 12611349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fatal case of malignant hyperthermia complicated by generalized compartment syndrome and rhabdomyolysis.
    Green G
    Acta Anaesthesiol Scand; 2003 May; 47(5):619-21. PubMed ID: 12699524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant hyperthermia in the otology patient: the UCLA experience.
    Wackym PA; Blackwell KE
    Am J Otol; 1994 May; 15(3):371-5. PubMed ID: 8579142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of malignant hyperthermia crisis during anesthesia].
    Amiel I; Nivoche Y
    Ann Fr Anesth Reanim; 1989; 8(5):427-34. PubMed ID: 2697157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant hyperthermia].
    Zimprich F; Kress HG; Zeitlhofer J
    Wien Klin Wochenschr; 2003 Sep; 115(15-16):556-62. PubMed ID: 14531168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant hyperthermia.
    Halliday NJ
    J Craniofac Surg; 2003 Sep; 14(5):800-2. PubMed ID: 14501352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs.
    Schütte JK; Becker S; Burmester S; Starosse A; Lenz D; Kröner L; Wappler F; Gerbershagen MU
    Eur J Anaesthesiol; 2011 Apr; 28(4):256-64. PubMed ID: 21513076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant hyperthermia: considerations for the general surgeon.
    Heggie JE
    Can J Surg; 2002 Oct; 45(5):369-72. PubMed ID: 12387544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Treatment Without Using Dantrolene Sodium on a Child Occurring Malignant Hyperthermia During Induction of General Anesthesia: A Case Report.
    Zheng Q; Liu N; Zeng Y; Chen Y; Zhang H; Su X; Zhuang J
    J Craniofac Surg; 2024 Jun; 35(4):e351-e354. PubMed ID: 38829149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.
    Ward A; Chaffman MO; Sorkin EM
    Drugs; 1986 Aug; 32(2):130-68. PubMed ID: 3527659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dantrolene--a review of its pharmacology, therapeutic use and new developments.
    Krause T; Gerbershagen MU; Fiege M; Weisshorn R; Wappler F
    Anaesthesia; 2004 Apr; 59(4):364-73. PubMed ID: 15023108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant hyperthermia].
    Chastonay P; Bracco D; Freymond D; Ravussin P
    Rev Med Suisse Romande; 1999 Mar; 119(3):191-202. PubMed ID: 10218414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.